“The global automation in biopharma market is estimated to reach USD 1.23 billion by 2025” says new Visiongain report

22 May 2020

Visiongain has launched a new report Automation in Biopharma Industry 2020-2030: Forecasts by Application (Clinical Stage and Drug Discovery Stage) and by Technologies (Automation Technology (DCS, SCADA, PLC, MES, HMI, APC, ERP, LIMS, CRM, CAPA) and Digital Technology (IoT, AI, Digital Twin, AR & VR, Predictive Analytics, Cloud Computing). Plus, Leading Companies Analysis.

The automation in biopharma market is projected to grow at a CAGR of 4.3% in the first half of the forecast period. In 2019, the automation market in biopharmaceutical industry in clinical stage accounted for 62.1% of the automation in biopharmaceutical market. Visiongain estimated that ERP automation in biopharma will be the driver for market growth in the first half of the forecast period.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

The 142-page Visiongain report provides clear detailed insight into the automation in biopharma market. Discover the key trends and development in the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Automation in biopharma market forecasts from 2020-2030

• This report assesses the application of automation in the biopharma market and gives revenue to 2030

• Provides qualitative analysis and forecast of the submarket by technology for the period 2020-2030:

• Automation Technology

• Digitization Technology
• IoT
• AI
• Digital Twin
• AR & VR
• Predictive Analytics
• Cloud Computing

• Profiles leading companies that will be important in the development of the automation in biopharma market. For each company, developments and outlooks are discussed and companies covered in this chapter include:
• PerkinElmer
• Thermo Fisher Scientific
• Sartorius
• Siemens
• Rockwell
• Zenith (Cognizant)
• RheoSense, Inc.
• Werum
• Emerson
• TetraScience

• Provides qualitative analysis of trends and developments that will affect the automation in biopharma market, from the perspective of biopharmaceutical companies, during the period 2020 to 2030.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Cancer Diagnostics Market Report 2021-2031

Major investments have been made by companies in the cancer diagnostics industry in the past few years to develop novel tests to capitalize on the opportunities in the untapped market.

19 April 2021


Visiongain Publishes Food for Special Medical Purpose (FSMP) Market Report 2020-2030

The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.

12 April 2021


Visiongain Publishes Cell-Based Assays Market Report to 2030

Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.

09 April 2021


Visiongain Publishes Cancer Biologics Therapies Market Report 2021-2031

The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

06 April 2021